Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.5434
+0.0144 (2.72%)
At close: Nov 17, 2026, 4:00 PM EST
0.5480
+0.0046 (0.85%)
After-hours: Nov 17, 2026, 5:13 PM EST
Valion Bio Employees
Valion Bio had 52 employees as of December 31, 2025. The number of employees increased by 45 or 642.86% compared to the previous year. That makes Valion Bio the 34,871st largest employer in the world and 4,638th in the United States.
Employees
52
Change (1Y)
45
Growth (1Y)
642.86%
Revenue / Employee
n/a
Profits / Employee
-$369,808
Market Cap
482.32K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 52 | 45 | 642.86% |
| Dec 31, 2024 | 7 | -2 | -22.22% |
| Dec 31, 2023 | 9 | -7 | -43.75% |
| Jun 30, 2023 | 11 | - | - |
| Dec 31, 2022 | 16 | 9 | 128.57% |
| Dec 31, 2021 | 7 | -1 | -12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Virax Biolabs Group | 26 |
| GeoVax Labs | 19 |
| Silexion Therapeutics | 14 |
| Decoy Therapeutics | 11 |
| Biodexa Pharmaceuticals | 11 |
| SciSparc | 3 |
VBIO News
- 9 hours ago - Valion Bio reports completion of 200-liter entolimod production run - TheFly
- 6 days ago - Valion Bio to discuss entolimod at RW Baird’s National Security Conference - TheFly
- 18 days ago - Valion Bio says AFRRI to evaluate therapeutic efficacy of entolimod - TheFly
- 20 days ago - Valion Bio announces data from NIAID, RNCP-funded safety study of Entolimod - TheFly
- 22 days ago - Valion Bio receives unsolicited acquisition interest in Velocity Bioworks - TheFly
- 27 days ago - Valion Bio unveils agenda to accelerate clinical pipeline, shareholder value - TheFly
- 27 days ago - Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value - Accesswire
- 4 weeks ago - Valion Bio files to sell 3.95M shares of common stock for holders - TheFly